BMY vs DLTH · P/E 17, rev $24.46B vs rev $565.2M
Bristol-Myers Squibb Company (BMY) versus Duluth Holdings Inc (DLTH) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Duluth Holdings Inc (DLTH) is a apparel retail company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DLTH revenue for 2026-02-01 was $565.2M. Net income was -$16.4M. Revenue was down 9.8% from 2025-02-02 to 2026-02-01. DLTH currently screens at market cap $74.0M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DLTH currently screens at market cap $74.0M.
Not investment advice. Open the BMY and DLTH stock pages for the full models.
Not investment advice.